Aviva Systems Biology

Founded in 2002, Aviva Systems Biology supports scientists in their basic research, preclinical, drug development, and diagnostics workflows. With an extensive portfolio of nearly 500,000 products for antibodies, proteins, and immunoassays and over 20 years of expertise in antibody and protein production, scientists can find the unique reagents and support they need for success in their work.

Aviva systems are unique because our reagents for rare and common targets and species can be found in our broad catalogue of antibodies, recombinant proteins, and ELISA Kits. Many of our clients come to us because we have the target coverage and product quality no other reagent supplier can match. Our approach to antibody development enables detection of protein variants for deeper characterization of protein function across species, cell type, and disease states.

In 2017, Aviva Systems Biology acquired GenWay Biotech, a leading provider of production and manufacturing services to the life science and diagnostic industry. The GenWay services have been fully integrated into Aviva and we partner with academic, biopharma and diagnostic labs to expand their resources with cost-effective expertise and solutions for:

• High throughput antibody characterization
• Mid- to large-scale antibody and protein production, including process development
• ELISA development and manufacturing
• Antibody conjugation

GMP antibody, protein, and assay manufacturing services are offered through our ISO 13485 certified services laboratory.